On May 5, 2016, the U.S. Food and Drug Administration (FDA) made available an advance version of the final rule “Deeming Tobacco Products to be Subject to the Federal Food, Drug, and Cosmetic Act, as Amended by the Family Smoking Prevention and Tobacco Control Act; Restrictions on the Sale and Distribution of Tobacco Products and Required Warning Statements for Tobacco Products.” This advance rule is to be published in the Federal Register on May 10, 2016. The rule deems products meeting the statutory definition of “tobacco product,” including premium cigars, subject to the Federal Food, Drug and Cosmetic Act (FD&C Act), as amended by the Family Smoking Prevention and Tobacco Control Act. A proposed exemption for premium cigars was not adopted by FDA. As a result, premium cigar manufacturers will need to consider their actions in response to the rule.
Attorney Seth A. Mailhot will provide an overview of this rule and its effects on the premium cigar industry, which includes:
- FDA's mandated schedule for compliance with the various requirements of the rule
- Action items for companies in the premium cigar industry
- Responsibilities for contract manufacturers and ingredient suppliers
- Requirements to be imposed on premium cigar retailers
- View of the future of FDA regulation over cigars
Click here to view the webinar recording.